The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab beyond progression: Impact of subsequent bevacizumab retreatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression.
 
Rebecca Ann Previs
No Relationships to Disclose
 
Daniel Spinosa
No Relationships to Disclose
 
Bryan M. Fellman
No Relationships to Disclose
 
Amelia Lorenzo
No Relationships to Disclose
 
Isabelle Mulder
No Relationships to Disclose
 
May Mahmoud
No Relationships to Disclose
 
Ahmed Enbaya
No Relationships to Disclose
 
Jean M. Hansen
No Relationships to Disclose
 
Lauren Patterson Cobb
No Relationships to Disclose
 
Pamela T. Soliman
Honoraria - Janssen Oncology
Consulting or Advisory Role - Clovis Oncology
Research Funding - Novartis (Inst)
 
Robert L. Coleman
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; GamaMabs Pharma; Genentech/Roche; Genmab; NCCN; Oncolytics; OncoMed; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Pharmaceuticals; Oncoquest; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Genetics; Oncoquest; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Merck (Inst); PharmaMar (Inst); Prima BioMed (Inst); TapImmune Inc. (Inst); Tesaro (Inst)
 
Shannon Neville Westin
Consulting or Advisory Role - AstraZeneca; BioAscent; Casdin Capital; Clovis Oncology; Genentech; Gerson Lehrman Group; Medivation; Medscape; Merck; Ovation Sciences; Pfizer; Roche; Tesaro; Vaniam Group; Vermillion; Watermark Research Partners
Research Funding - ArQule; AstraZeneca; Bayer; Biomarin; Celgene (I); Clovis Oncology; Cotinga Pharmaceuticals; Critical Outcome Technologies; Karyopharm Therapeutics (I); Kite, a Gilead company (I); Novartis; Roche/Genentech; Tesaro